Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
11/08/26	HK$0.1330	+1.53%	0
10/08/26	HK$0.1310	+3.15%	1,190,000
07/08/26	HK$0.1270	0.00%	0
06/08/26	HK$0.1270	0.00%	100,000
05/08/26	HK$0.1270	0.00%	0

Delayed Quote Hong Kong S.E.

More quotes

Income Statement and Estimates

More financial data

Market Closed - Hong Kong S.E. Other stock markets 12:08:13 11/08/2026 +04			5-day change	1st Jan Change
0.1330 ^HKD	+1.53%		+4.72%	+1.53%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	105M 13.36M 11.56M 10.81M 9.88M 18.62M 1.27B 18.91M 127M 49.73M 637M 50.16M 49.06M 2.12B	P/E 2025	9.13x	P/E 2026	12.5x
Enterprise Value	49.45M 6.3M 5.46M 5.1M 4.66M 8.78M 601M 8.92M 59.8M 23.47M 301M 23.67M 23.15M 1B	EV / Sales 2025	0.25x	EV / Sales 2026	0.49x
Free-Float	27.02%	Yield 2025	2.31%	Yield 2026	1.91%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
21/06/25	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/05/25	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/03/25	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/11/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/11/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/09/23	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
11/08/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 day	+1.53%
1 week	+4.72%
Current month	+0.76%
1 month	+1.53%
3 months	-10.74%
6 months	-5.00%
Current year	+1.53%

Grand Brilliance Group Holdings Limited Stock

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation: Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news : Grand Brilliance Group Holdings Limited

Quotes and Performance

Course Extremes

Managers and Directors: Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	0.13	0.13
1 month	0.12	0.14
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	01/03/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Wai Man Lau SAM	Sales & Marketing	39	01/02/2015

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	01/03/2018
Yin Shun Miu BRD	Director/Board Member	59	18/09/2017
Man Wai Chiu BRD	Director/Board Member	57	18/09/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	+1.53%	+4.72%	+15.65%	+77.33%	13.36M
HENRY SCHEIN, INC.	-0.06%	+1.81%	+33.58%	+15.20%	9.82B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	+2.52%	+7.37%	-	-	1.47B
SHIP HEALTHCARE HOLDINGS, INC.	-4.67%	-6.78%	+6.08%	-4.73%	1.35B
AS ONE CORPORATION	-0.31%	-1.24%	-7.12%	-16.41%	1.07B
COWEALTH MEDICAL CHINA CO.,LTD.	+1.86%	+16.64%	+73.83%	+30.91%	745M
GKHT MEDICAL TECHNOLOGY CO., LTD.	+1.25%	+1.37%	-21.05%	-61.98%	615M
EXCELSIOR MEDICAL CO., LTD.	+1.14%	+1.71%	-13.07%	-8.62%	416M
NIPPON CARE SUPPLY CO., LTD.	+0.12%	+7.91%	+97.62%	+148.80%	407M
WIN-PARTNERS CO., LTD.	-0.47%	-3.38%	-6.60%	+18.89%	218M
Average	+0.29%	+1,032.17%	+19.88%	+22.16%	1.61B
Weighted average by Cap.	-0.06%	+536.02%	+27.67%	+11.76%

	2025	2026
Net sales	94.45M 12.04M 10.42M 9.74M 8.9M 16.78M 1.15B 17.04M 114M 44.82M 574M 45.2M 44.22M 1.91B	101M 12.84M 11.11M 10.39M 9.49M 17.89M 1.22B 18.17M 122M 47.8M 612M 48.2M 47.15M 2.04B
Net income	9.46M 1.21M 1.04M 976K 892K 1.68M 115M 1.71M 11.44M 4.49M 57.53M 4.53M 4.43M 192M	8.41M 1.07M 928K 868K 793K 1.49M 102M 1.52M 10.17M 3.99M 51.16M 4.03M 3.94M 170M
Net Debt	-62.36M -7.95M -6.88M -6.43M -5.88M -11.08M -758M -11.25M -75.43M -29.6M -379M -29.85M -29.2M -1.26B	-55.35M -7.06M -6.11M -5.71M -5.22M -9.83M -673M -9.99M -66.94M -26.27M -337M -26.49M -25.91M -1.12B